Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Non-anesthesiologist administration of propofol for gastrointestinal endoscopy: European Society of Gastrointestinal Endoscopy, European Society of Gastroenterology and Endoscopy Nurses and Associates Guideline - Updated June 2015

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Endoscopic submucosal dissection: European Society of Gastrointestinal Endoscopy (ESGE) Guideline

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Three-dimensional motion tracking correlates with skill level in upper gastrointestinal endoscopy

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Assessment of competence in ERCP

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. The EFSUMB Guidelines and Recommendations for the Clinical Practice of Elastography in Non-Hepatic Applications: Update 2018

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Esophageal stenting for benign and malignant disease: European Society of Gastrointestinal Endoscopy (ESGE) Cascade Guideline

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Subtyping of intraductal papillary mucinous neoplasms - pitfalls of MUC1 immunohistochemistry

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Next generation sequencing of endoscopic ultrasound guided microbiopsies from pancreatic cystic neoplasms

    Research output: Contribution to journalJournal articleResearchpeer-review

  • Jean-Marc Dumonceau
  • Andrea Riphaus
  • Florian Schreiber
  • Peter Vilmann
  • Ulrike Beilenhoff
  • Jose R Aparicio
  • John J Vargo
  • Maria Manolaraki
  • Caroline Wientjes
  • István Rácz
  • Cesare Hassan
  • Gregorios Paspatis
View graph of relations

This Guideline is an official statement of the European Society of Gastrointestinal Endoscopy (ESGE) and the European Society of Gastroenterology and Endoscopy Nurses and Associates (ESGENA). It addresses the administration of propofol by non-anesthesiologists for gastrointestinal (GI) endoscopy. Main Recommendations 1 We recommend that the type of endoscopic procedure and the patient's American Society of Anesthesiologists (ASA) physical status, age, body mass index, Mallampati's classification, and risk factors for obstructive sleep apnea (OSA) be assessed before each procedure with non-anesthesiologist administration of propofol (NAAP) (strong recommendation, moderate quality evidence). 2 We suggest primary involvement of an anesthesiologist in patients of ASA class ≥ 3, with a Mallampati's class ≥ 3 or other conditions that put them at risk of airway obstruction (e. g. pharyngolaryngeal tumors), in patients who chronically receive significant amounts of narcotic analgesics, or in cases where a long-lasting procedure is anticipated (weak recommendation, low quality evidence). 3 We suggest consideration of capnographic monitoring during NAAP in specific situations including high risk patients, intended deep sedation, and long procedures (weak recommendation, high quality evidence). 4 We suggest propofol monotherapy except in particular situations (weak recommendation, high quality evidence). 5 We recommend administering propofol through intermittent bolus infusion or perfusor systems, including target-controlled infusion (TCI), and consideration of patient-controlled sedation (PCS) in particular situations (strong recommendation, high quality evidence). 6 We suggest that patients listen to self-selected music during upper and lower GI endoscopy procedures (weak recommendation, moderate quality evidence). 7 We do not suggest using pharyngeal anesthesia during propofol sedation for upper GI endoscopy (weak recommendation, moderate quality evidence). 8 We suggest using the post-anesthetic discharge scoring system (PADSS) to determine when patient recovery is sufficient to allow discharge (weak recommendation, low quality evidence). 9 Minimum discharge criteria should be fulfilled before discharging a patient. We recommend that patients who have received combined regimens, and all patients of ASA class > 2, should upon discharge be accompanied by a responsible person and refrain for 24 hours from driving, drinking alcohol, operating heavy machinery, or engaging in legally binding decisions. Advice should be provided verbally and in written form to the patient, including a 24-hour contact phone number (strong recommendation, low quality evidence). 10 For patients of ASA classes 1 - 2 who have received low dose propofol monotherapy, a 6-hour limit is suggested (weak recommendation, low quality evidence).

Original languageEnglish
JournalEndoskopie
Volume47
Issue number12
Pages (from-to)1175-89
Number of pages15
ISSN1211-1074
DOIs
Publication statusPublished - Dec 2015

ID: 45990860